Nahum Puebla

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Nahum Puebla is an Assistant Professor at The University of Texas MD Anderson Cancer Center, USA. His research primarily focuses on enhancing the effectiveness of immunotherapy in various cancer types, including metastatic melanoma and diffuse large B cell lymphoma. Recent contributions include studies on the combination of low-dose radiation with immunotherapy, the utilization of engineered IL-2 in conjunction with PD-1 blockade, and the application of novel techniques in CAR T cell therapy.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Navin Varadarajan

Professor

University of Houston

UNITED STATES

View details

Swaminathan P. Iyer

Professor of Medicine

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nahum Puebla

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects

Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy.

Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling.

Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy

Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection

Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report.

Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer

The RadScopal Technique as an Immune Adjuvant to Treat Cancer

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

Selective Agonism of Intermediate-Affinity IL-2 Receptor Promotes Systemic Antitumor Responses in Combination with Radiotherapy in Metastatic Lung Cancer

Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance

Pulsed radiotherapy to mitigate high tumor burden and generate immune memory

Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer

Collaborators (2)

Navin Varadarajan

Swaminathan P. Iyer

Make your next move.